Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

9479	Companies
185510	Keywords
117899	Articles
99364	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 04/08/2025 at 14:35, 7 months 27 days ago

Jaguar Health Showcases Gelclair at Oncology Nursing Society Congress

Cancer Care Jaguar Health Gelclair Oral Mucositis Oncology Nursing Society
PRESS RELEASE

published on 04/08/2025 at 14:30, 7 months 27 days ago

Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product
Jaguar Health, Inc. (NASDAQ:JAGX) announces Napo Pharmaceuticals' participation in the 50th Oncology Nursing Society Congress to showcase Gelclair® for oral mucositis relief in cancer patients

Napo Pharmaceuticals Cancer Care Jaguar Health Gelclair Oral Mucositis
BRIEF

published on 04/04/2025 at 22:20, 8 months ago

Jaguar Health Awards New Employee Inducement Grants

Stock Options Restricted Stock Units Jaguar Health Nasdaq Listing Rule Employee Inducement
PRESS RELEASE

published on 04/04/2025 at 22:15, 8 months ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. grants RSUs and stock options to new employees and outlines vesting terms. Also, provides an overview of the Jaguar Health Family of Companies' focus

Stock Options Jaguar Health RSUs New Employees Vesting Terms
BRIEF

published on 04/01/2025 at 22:20, 8 months 3 days ago

Jaguar Health Completes Bridge Financing

Private Placement Warrants Jaguar Health Convertible Notes Crofelemer Development
PRESS RELEASE

published on 04/01/2025 at 22:15, 8 months 3 days ago

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announces the closing of a private placement, issuing convertible promissory notes and unregistered warrants to selected investors, with gross proceeds of approximately $3.448 million

Private Placement Warrants Fundraising Jaguar Health Convertible Notes
BRIEF

published on 03/31/2025 at 14:05, 8 months 5 days ago

Jaguar Health Shows 20% Revenue Growth in 2024

Financial Results Jaguar Health Prescription Products FDA Meeting 2024 Revenue Growth
PRESS RELEASE

published on 03/31/2025 at 14:00, 8 months 5 days ago

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023
Jaguar Health, Inc. reports a 20% increase in total net revenue for 2024, reaching $11.7 million. Expecting first results in Q2 2025 for crofelemer trials. FDA meeting scheduled for Phase 3 OnTarget trial

Financial Results Jaguar Health Net Revenue FDA Meeting POC Trials
BRIEF

published on 03/28/2025 at 14:05, 8 months 8 days ago

Jaguar Health Highlights Veterinary Support for Canalevia-CA1

FDA Approval Canalevia-CA1 Veterinary Oncology Dog Chemotherapy Non-Antimicrobial Treatment
PRESS RELEASE

published on 03/28/2025 at 14:00, 8 months 8 days ago

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
Jaguar Health's Canalevia-CA1 receives FDA approval for chemotherapy-induced diarrhea in dogs, addressing a critical unmet need in veterinary oncology

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Veterinary Oncology

Accesswire

Published on 12/05/2025 at 17:15, 49 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 4 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 4 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 19 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 2 hours 29 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:51, 12 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 18 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 4 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 39 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 54 minutes ago

Reorganization of the Eckert & Ziegler Executive Board

Les Echos

Published on 12/05/2025 at 17:18, 46 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 53 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 9 hours 19 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 1 day ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 1 day ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE